Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Insys Therapeutics Company Profile (NASDAQ:INSY)

Consensus Ratings for Insys Therapeutics (NASDAQ:INSY) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $62.33 (84.91% upside)

Analysts' Ratings History for Insys Therapeutics (NASDAQ:INSY)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/5/2014OppenheimerBoost Price Target$30.67 -> $58.67ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014JMP SecuritiesBoost Price TargetOutperform$33.33 -> $66.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013JMP SecuritiesBoost Price TargetMarket Outperform$20.00 -> $33.33ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013OppenheimerBoost Price TargetOutperform$19.33 -> $30.67ViewTweet This Rating  Share This Rating on StockTwits
8/14/2013JMP SecuritiesSet Price Target$12.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
8/14/2013OppenheimerBoost Price TargetOutperform$15.33 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2013Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
7/31/2013OppenheimerInitiated CoverageOutperform -> Outperform$15.33ViewTweet This Rating  Share This Rating on StockTwits
6/27/2013JMP SecuritiesBoost Price Target$10.67 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
5/28/2013JMP SecuritiesInitiated CoverageOutperform$10.67ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 9/22/2012 forward)
Discuss Insys Therapeutics